Patients with TD who require continued treatment with an antipsychotic may benefit from atypical antipsychotics, such as risperidone, olanzapine, aripiprazole, and clozapine, as these agents seem to carry less risk for TD. Butyrophenones, diphenylbutylpiperidines, and phenothiazines are all first-generation (or typical) antipsychotics and carry a greater risk for TD. Therefore, these drugs should be avoided in patients with TD who require long-term antipsychotic treatment.
Learn more about the management of TD.
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Christoph U. Correll. Fast Five Quiz: Tardive Dyskinesia Management - Medscape - Feb 22, 2021.
Comments